Simply in the past years, researchers have recognized the big role that the microorganisms living inside and on us play in our health. The human microbiome, and especially the gut microbiome, has been linked to several chronic diseases, including diabetes. An unbalanced microbiome structure has been found in patients with diabetes, who tend to have a less varied gut microbiome as compared to healthy people. Deals June.
Some companies are developing diabetes treatments targeting the microbiome. The French Valviotis is currently conducting preclinical testing of a drug intended at increasing the microbiome variety as a treatment for type 2 diabetes. Although promising, the microbiome field is extremely young and its intricacy makes it tough to establish causation after finding connection.
That world might not be up until now away, as numerous companies are establishing non-invasive methods to replace finger pricking. Deals June. Stability Applications has actually established a device called GlucoTrack that can determine glucose using electro-magnetic waves and is already offered in Europe. Similar innovations are popping up, with GlucoSense in London using laser light to measure sugar levels and MediWise utilizing radio waves.
The GlucoWise sensing unit prototypePatches are also becoming a popular form of determining blood glucose without needles, such as FreeStyle Libre, an inch-wide patch that can be used for as much as 2 weeks. At the University of Bath, scientists are establishing a graphene patch that might offer greater precision by measuring sugar levels separately in multiple hair roots – Deals June.
Meanwhile, Senseonic and Roche are working on a device that is implanted under the skin. Deals June. Still, non-invasive alternatives to determine blood sugar frequently face problems concerning accuracy. The popular glucose-measuring contact lens that Google announced in 2014 was dismissed as “technically infeasible” and even more developments will be required to reach the degree of accuracy of finger-pricking methods.
Researchers are currently speculating about microchips that can diagnose diabetes type 1 prior to the symptoms appear or nanorobots taking a trip in the blood stream while they determine glucose and provide insulin – Deals June.”There’s little fiction left in this. I strongly think that microrobotics will come and will belong to our drug delivery within the next 10 years,” said Tomas Landh, Director of Strategy and Innovation Sourcing at Novo Nordisk, at the 2013 Medicon Valley Alliance Yearly MeetingWhatever the future brings, it will undoubtedly make a huge distinction in the lives of countless individuals worldwide.